Shares of Kenvue Inc. slid 4.09% to $16.17 Thursday, on what proved to be an all-around rough trading session for the stock ...

Earlier this week, the Trump administration publicly warned of a possible link between prenatal Tylenol use and autism, ...

Kenvue shares rose 6% in premarket trading on Tuesday, set to rebound from a record low hit in the previous session as U.S.

Economists saw “limited” risk to the pharmaceutical firm’s stock, despite some expected impact on Tylenol consumption.

Shares may be rising because investors expected the White House to announce stricter regulations on the medication, Citi ...

Analysts saw no new scientific evidence from the White House to support President Donald Trump linking Tylenol to autism.

President Donald Trump created a potentially existential crisis for Tylenol maker Kenvue Inc. with just three words about the ...

Independent, sound science clearly shows that taking acetaminophen does not cause autism,” a Kenvue spokesperson told ...

The White House is reportedly planning to link Tylenol use during pregnancy to autism. The news pushed Kenvue stock down 8%.

President Donald Trump is set to speak today on how Tylenol may be linked to autism. Here's when, who makes Tylenol, and ...

Shares of consumer healthcare firm Kevnue dropped to a record low during regular trading Monday, then made up some ground ...

Here are some of the stocks making notable moves in Tuesday's premarket action: Kenvue shares are rallying 6% off a record ...